Hamilton Locke advised Tryptamine Therapeutics Limited on the deal.Tryptamine Therapeutics Limited secured the acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously listed…
Tryptamine Therapeutics Limited’s Acquisition and Backdoor Listing of Tryp Therapeutics
![](https://globallegalchronicle.com/wp-content/uploads/2024/06/tryptamine-therapeutics-limiteds-acquisition-and-backdoor-listing-of-tryp-therapeutics_666bec9d1e0c3-480x360.jpeg)